Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/07 | 1,360 | 1,432 | 1,295 | 1,301 | -49 | -3.6% | 1,713,600 |
| 2023/04/06 | 1,441 | 1,461 | 1,322 | 1,350 | -127 | -8.6% | 2,112,700 |
| 2023/04/05 | 1,306 | 1,560 | 1,305 | 1,477 | +156 | +11.8% | 7,468,400 |
| 2023/04/04 | 1,500 | 1,538 | 1,259 | 1,321 | -9 | -0.7% | 4,986,200 |
| 2023/04/03 | 1,330 | 1,330 | 1,330 | 1,330 | +300 | +29.1% | 33,900 |
| 2023/03/31 | 1,041 | 1,058 | 1,026 | 1,030 | -16 | -1.5% | 256,900 |
| 2023/03/30 | 1,045 | 1,072 | 1,030 | 1,046 | +11 | +1.1% | 425,400 |
| 2023/03/29 | 1,063 | 1,076 | 1,024 | 1,035 | -53 | -4.9% | 592,700 |
| 2023/03/28 | 1,113 | 1,127 | 1,074 | 1,088 | -12 | -1.1% | 506,100 |
| 2023/03/27 | 1,204 | 1,220 | 1,094 | 1,100 | -164 | -13% | 1,225,400 |
| 2023/03/24 | 1,227 | 1,280 | 1,197 | 1,264 | +42 | +3.4% | 573,400 |
| 2023/03/23 | 1,211 | 1,240 | 1,181 | 1,222 | +7 | +0.6% | 466,200 |
| 2023/03/22 | 1,304 | 1,310 | 1,200 | 1,215 | -72 | -5.6% | 771,400 |
| 2023/03/20 | 1,339 | 1,345 | 1,275 | 1,287 | -58 | -4.3% | 536,600 |
| 2023/03/17 | 1,293 | 1,358 | 1,275 | 1,345 | +73 | +5.7% | 847,000 |
| 2023/03/16 | 1,212 | 1,282 | 1,190 | 1,272 | +34 | +2.7% | 805,900 |
| 2023/03/15 | 1,215 | 1,262 | 1,176 | 1,238 | +63 | +5.4% | 1,009,200 |
| 2023/03/14 | 1,278 | 1,324 | 1,165 | 1,175 | -103 | -8.1% | 1,294,800 |
| 2023/03/13 | 1,305 | 1,328 | 1,231 | 1,278 | -98 | -7.1% | 1,457,700 |
| 2023/03/10 | 1,271 | 1,400 | 1,256 | 1,376 | +104 | +8.2% | 2,239,100 |
| 2023/03/09 | 1,251 | 1,430 | 1,225 | 1,272 | +9 | +0.7% | 3,987,500 |
| 2023/03/08 | 1,324 | 1,360 | 1,230 | 1,263 | -91 | -6.7% | 1,742,800 |
| 2023/03/07 | 1,314 | 1,358 | 1,276 | 1,354 | +67 | +5.2% | 1,089,200 |
| 2023/03/06 | 1,373 | 1,378 | 1,257 | 1,287 | -144 | -10.1% | 2,047,100 |
| 2023/03/03 | 1,246 | 1,450 | 1,218 | 1,431 | +194 | +15.7% | 2,248,100 |
| 2023/03/02 | 1,328 | 1,369 | 1,170 | 1,237 | -49 | -3.8% | 2,827,700 |
| 2023/03/01 | 1,446 | 1,510 | 1,286 | 1,286 | -179 | -12.2% | 2,657,500 |
| 2023/02/28 | 1,391 | 1,504 | 1,375 | 1,465 | +84 | +6.1% | 4,041,700 |
| 2023/02/27 | 1,200 | 1,432 | 1,184 | 1,381 | +229 | +19.9% | 5,418,300 |
| 2023/02/24 | 1,107 | 1,152 | 1,096 | 1,152 | +27 | +2.4% | 264,700 |
| 2023/02/22 | 1,152 | 1,165 | 1,114 | 1,125 | -49 | -4.2% | 530,200 |
| 2023/02/21 | 1,192 | 1,244 | 1,155 | 1,174 | ±0 | ±0% | 746,000 |
| 2023/02/20 | 1,176 | 1,240 | 1,155 | 1,174 | -29 | -2.4% | 794,800 |
| 2023/02/17 | 1,241 | 1,277 | 1,182 | 1,203 | -43 | -3.5% | 1,687,500 |
| 2023/02/16 | 1,145 | 1,324 | 1,119 | 1,246 | +107 | +9.4% | 3,098,300 |
| 2023/02/15 | 1,043 | 1,148 | 1,038 | 1,139 | +141 | +14.1% | 1,396,300 |
| 2023/02/14 | 1,047 | 1,047 | 990 | 998 | -79 | -7.3% | 657,900 |
| 2023/02/13 | 1,022 | 1,082 | 1,010 | 1,077 | +47 | +4.6% | 618,200 |
| 2023/02/10 | 1,021 | 1,040 | 1,002 | 1,030 | -4 | -0.4% | 295,500 |
| 2023/02/09 | 1,038 | 1,060 | 1,031 | 1,034 | -20 | -1.9% | 252,400 |
| 2023/02/08 | 1,063 | 1,070 | 1,042 | 1,054 | -18 | -1.7% | 248,600 |
| 2023/02/07 | 1,069 | 1,090 | 1,052 | 1,072 | ±0 | ±0% | 283,200 |
| 2023/02/06 | 1,069 | 1,102 | 1,052 | 1,072 | -7 | -0.6% | 303,800 |
| 2023/02/03 | 1,148 | 1,162 | 1,074 | 1,079 | -91 | -7.8% | 721,900 |
| 2023/02/02 | 1,142 | 1,199 | 1,134 | 1,170 | +36 | +3.2% | 355,300 |
| 2023/02/01 | 1,134 | 1,165 | 1,106 | 1,134 | +5 | +0.4% | 227,000 |
| 2023/01/31 | 1,111 | 1,135 | 1,095 | 1,129 | -3 | -0.3% | 231,600 |
| 2023/01/30 | 1,106 | 1,153 | 1,086 | 1,132 | +8 | +0.7% | 613,700 |
| 2023/01/27 | 1,180 | 1,184 | 1,120 | 1,124 | -70 | -5.9% | 556,600 |
| 2023/01/26 | 1,258 | 1,267 | 1,130 | 1,194 | -64 | -5.1% | 1,168,300 |
401～
450
件表示中 / 1492件
類似銘柄と比較する
現在ご覧いただいている「ＤＥＬＴＡ－Ｐ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＤＥＬＴＡ－Ｐ | 51,900円 | - | - | 0.00% | - | 14.89倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入ｉＰＳ由来細胞医薬や抗体医薬開発に注力 |
| 免疫生物 | 50,000円 | +13.4% | -4.0% | 0.00% | 40.49倍 | 3.49倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
| ファンペップ | 14,000円 | - | - | 0.00% | - | 2.12倍 |
|
大阪大医研発。患者の体内で抗体の産生を誘導する抗体誘導ペプチドを用いた医薬品を開発 |
市場注目の銘柄
チャート関連のコラム
